Which drugs does patent 7,192,938 protect, and when does it expire?
Patent 7,192,938 protects BONIVA and ACTONEL and is included in two NDAs. There have been zero Paragraph IV challenges on Actonel and
Protection for ACTONEL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-five patent family members in thirty-two countries.